Article Text

PDF
Does calcium cause the different effects of Gelofusine and Haemaccel on coagulation?
  1. T J Coats1,
  2. M Heron2
  1. 1Academic Unit of Emergency Medicine, Leicester University, Leicester, UK
  2. 2Emergency Department, Bart’s and The Royal London Hospital, London, UK
  1. Correspondence to:
 Professor T J Coats
 Professor of Emergency Medicine, Leicester University, Leicester Royal Infirmary, Infirmary Square, Leicester, LE1 5WW, UK; t.coats{at}virgin.net

Abstract

Background: Gelofusine (which does not contain calcium) has a greater effect on coagulation than Haemaccel (which contains 6.25 mmol/l of calcium). This in vitro study was performed to assess whether calcium might be the cause of the different effects on coagulation.

Methods: Three solutions were compared; (a) Gelofusine, (b) Gelofusine with calcium added to 6.25 mmol/l, and (c) Haemaccel. Thromboelastography (Sonoclot) was used to examine whole blood coagulation, with time to peak clot weight as the primary outcome measure.

Results: There was no significant difference between the Gelofusine containing solutions. Both Gelofusine solutions gave a greater impairment of coagulation than the Haemaccel solution.

Conclusions: The different effect of Gelofusine on coagulation compared with Haemaccel does not seem to be related to the different calcium contents of the solutions.

  • APTT, activated partial thromboplastin time
  • INR, international normalised ratio
  • resuscitation
  • blood coagulation
  • succinylated gelatin
  • polygeline
  • fluid therapy

Statistics from Altmetric.com

Footnotes

  • Competing interests: none declared

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.